SECOND EXTENSION - GRANTED
granted
on 08 May 2024
Last Applicant/ Owned by
228 Park Ave. South
New York
NY
10003
Serial Number
97334141 filed on 28th Mar 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
TORNADO THERAPEUTICS
Pharmaceutical preparations and substances for the prevention of age-related physical decline, age-related diseases, infectious diseases, and Covid-19; pharmaceutical preparations and substances for the treatment of autoimmune diseases and inflammatory conditions, infectious diseases, fungal infections, mitochondrial myopathy and mitochondrial stress, oncology indications, metabolic indications, c Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances for the prevention of age-related physical decline, age-related diseases, infectious diseases, and Covid-19; pharmaceutical preparations and substances for the treatment of autoimmune diseases and inflammatory conditions, infectious diseases, fungal infections, mitochondrial myopathy and mitochondrial stress, oncology indications, metabolic indications, cardiovascular indications, neurodegenerative indications, and indications mediated by the mTOR pathway
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97334141
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 0735790
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 09th May 2024 | CORRECTED NOA E-MAILED |
| 08th May 2024 | SOU EXTENSION 2 GRANTED |
| 08th May 2024 | DIVISIONAL PROCESSING COMPLETE |
| 29th Apr 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 08th Apr 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| 08th Apr 2024 | SOU EXTENSION 2 FILED |
| 08th Apr 2024 | DIVISIONAL REQUEST RECEIVED |
| 04th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
| 14th Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |